Infection, Immunity and Inflammation Theme, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia.
Clin Cancer Res. 2022 Nov 1;28(21):4677-4688. doi: 10.1158/1078-0432.CCR-22-1332.
The tumor immune microenvironment impacts the biological behavior of the tumor, but its effect on clinical outcomes in head and neck cutaneous squamous cell carcinomas (HNcSCC) is largely unknown.
We compared the immune milieu of high-risk HNcSCC that never progressed to metastasis with those that metastasized using multiparameter imaging mass cytometry. The cohort included both immunosuppressed patients (IS) and patients with an absence of clinical immune-suppression (ACIS). Spatial analyses were used to identify cellular interactions that were associated with tumor behavior.
Nonprogressing primary HNcSCC were characterized by higher CD8+ and CD4+ T-cell responses, including numerically increased regulatory T cells. In contrast, primary lesions from HNcSCC patients who progressed were largely devoid of T cells with lower numbers of innate immune cells and increased expression of checkpoint receptors and in the metastatic lesions were characterized by an accumulation of B cells. Spatial analysis reveals multiple cellular interactions associated with nonprogressing primary tumors that were distinct in primary tumors of disease-progressing patients. Cellular regional analysis of the tumor microenvironment also shows squamous cell-enriched tumor regions associated with primary nonprogressing tumors.
Effective responses from both CD8+ and CD4+ T cells in the tumor microenvironment are essential for immune control of primary HNcSCC. Our findings indicate that the early events that shape the immune responses in primary tumors dictate progression and disease outcomes in HNcSCC.
肿瘤免疫微环境影响肿瘤的生物学行为,但它对头颈皮肤鳞状细胞癌(HNcSCC)临床结局的影响在很大程度上尚不清楚。
我们比较了高风险 HNcSCC 中从未进展为转移的肿瘤与发生转移的肿瘤的免疫微环境,这些患者使用多参数成像质谱细胞术进行了检测。该队列包括免疫抑制患者(IS)和无临床免疫抑制(ACIS)患者。空间分析用于识别与肿瘤行为相关的细胞相互作用。
非进展性原发性 HNcSCC 的特征是 CD8+和 CD4+T 细胞反应更高,包括数量增加的调节性 T 细胞。相比之下,进展性 HNcSCC 患者的原发性肿瘤中几乎没有 T 细胞,固有免疫细胞数量减少,检查点受体表达增加,转移性病变中 B 细胞积累。空间分析揭示了与非进展性原发性肿瘤相关的多种细胞相互作用,这些相互作用在进展性疾病患者的原发性肿瘤中是不同的。肿瘤微环境的细胞区域分析还显示与原发性非进展性肿瘤相关的富含鳞状细胞的肿瘤区域。
肿瘤微环境中 CD8+和 CD4+T 细胞的有效反应对于控制原发性 HNcSCC 的免疫至关重要。我们的研究结果表明,塑造原发性肿瘤中免疫反应的早期事件决定了 HNcSCC 的进展和疾病结局。